Will Older Patients Lose Out With Proposed Changes To NICE?

Recent Proposed Changes to the way in which treatments are evaluated for the NHS, some say, could lead to restricted access to certain drugs-particularly for older patients. What does NICE have to say about this? Read here to find out. (Source: Optometry Today, 1/16/14).

You might also be interested in:

NICE Report: Cancer Drugs Priced According to Effectiveness… February 25, 2019
Study: Moving Some Plans to Part D Could Cut Spending, but Not… January 17, 2019
Report: NHS Patient Data Could be Worth Billions July 25, 2019
Gottlieb Says Insurers Must Take Risk on Biosimilars March 20, 2019
PhRMA: Report Shows How IPI Model Would Negatively Impact Access January 16, 2019
ICER Unveils Proposed Changes to Value Assessment Framework August 22, 2019
PhRMA Responds to OIG's Rebate Proposal April 9, 2019